Radiation Toxicity
(Radiation Sickness, Acute Radiation Syndrome) Market
Radiation Toxicity (Radiation Sickness, Acute
Radiation Syndrome) Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Growth
The Radiation Toxicity market, encompassing Radiation Sickness and Acute Radiation Syndrome, is projected to grow significantly due to rising nuclear incidents and medical advancements. The market size is estimated to reach approximately $1.2 billion by 2028, driven by increased awareness, diagnostic innovation, and enhanced treatment protocols addressing radiation exposure effects.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Aeolus Pharmaceuticals, Inc.
◍ Atox Bio Ltd
◍ BCN Biosciences LLC
◍ Cellphire Inc
◍ Daiichi Sankyo Co Ltd
◍ FirstString Research Inc
◍ RxBio Inc
◍ Shuttle Pharmaceuticals LLC
The Radiation Toxicity Market features companies like Aeolus Pharmaceuticals, developing treatments for radiation exposure; Atox Bio, focusing on countermeasures; and Daiichi Sankyo, advancing therapies. These firms contribute through innovative therapies and research, enhancing market growth. Sales revenues, although proprietary, indicate significant investment into radiation-related therapeutics.
